JAZZ Jazz Pharmaceuticals plc
JAZZ Jazz Pharmaceuticals plc
Healthcare · Biotechnology
Desk view
Market read
POC $166.06 · VWAP $201.78 · +6.1% vs 12m avg buyer
Insiders selling 0 buy / 1 sell · Form 4, 90d $19.2M sold last open-market sell Iannone Robert
Cluster CEO, EVP + 1 other sold $2.3M, Sep 2–14
Coverage
1 watchlist
JAZZ Price Structure
Loading timeframes…
Peers
Every watchlist JAZZ belongs to, members best 30-day change first — JAZZ highlighted in place. Each pill: 30d change, 1d/7d, and a close spark over the last 30 calendar days (~21 sessions); hover for price, RSI, and the full chart.
@monster-discoveries
Against street estimates
How JAZZ's reported EPS compared with analyst consensus. Street estimates are single-source vendor consensus (yfinance). Actuals are vendor consensus-basis EPS (often non-GAAP); edgarEps is GAAP diluted from filings — disputed flags large disagreement only. A consensus out of line with the name's earlier estimates (opposite sign to all of them and over 3x their size) is not graded. EPS only.
Recent news
Headlines about JAZZ from the desk's news pull — links go to the publisher. Not a desk read: the market read above is the desk's own.
pulled 14 days ago · Oct 9
- Jazz Pharmaceuticals (JAZZ) Stock Price & Overview
- Jazz Pharmaceuticals (JAZZ) Stock Price & Overview
- Jazz Pharmaceuticals plc, JAZZ, FDA Calendar, PDUFA Date - RTTNews
- jazz-20260915
- Jazz Pharmaceuticals Announces Second Quarter 2026 Financial Results
“On or before” marks an article that arrived without a publish date — the date shown is when the desk pulled it, so the article is at least that old.
JAZZ research tape
52 dated scans, research, and events, newest first — the full record. Desk commentary and scheduled prints sit in their own panes.